5-Amino-1MQ 10mg Injection Dosage: What Research Shows

A 5-amino-1MQ 10mg injection dosage guide covering reconstitution math, reported research protocols, and why no human dose is established yet.

ARTICLE OVERVIEW

A 5-amino-1MQ 10mg injection dosage guide covering reconstitution math, reported research protocols, and why no human dose is established yet.

There is no established human dosage for a 5-amino-1MQ 10mg injection. 5-amino-1MQ is a research-only compound that has never been tested in controlled human trials, so every number circulating online comes from rodent data or anecdotal reports rather than clinical evidence. Treat any "standard" protocol you see as experimental, not medical guidance.

What 5-Amino-1MQ Is — and Why 10mg Vials Are Common

5-amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase, or NNMT. In rodent studies, blocking NNMT has been linked to changes in fat cell metabolism and NAD+ availability. That research interest, not human data, is what drives demand.

Suppliers typically sell it as a 10 mg lyophilized powder in a sealed vial. Because it ships as a dry powder, the 10 mg figure describes the vial's total contents — not a dose. Turning it into an injectable requires reconstitution with bacteriostatic water, which is where most dosage confusion starts.

5-amino-1MQ is not FDA-approved for human use in the United States. Vials are labeled "for research use only," and that label is not a formality.

Is There a Real 5-Amino-1MQ Injection Dosage?

No. There is no published human dose, no established half-life, and no safety ceiling for 5-amino-1MQ. Researchers have used milligram-per-kilogram amounts in mice, and those figures cannot be converted directly into a human injection.

What exists instead is community lore. Forum posts describing a 5-amino-1mq subcutaneous injection dosage often land between 2.5 mg and 10 mg per day, but those numbers were never validated in a clinical setting. They are anecdotes repeated until they sound like standards.

  • No phase 1 human trial has reported pharmacokinetics or tolerability.
  • No maximum tolerated dose has been established.
  • No long-term safety data exists for any route of administration.

Because of that gap, a physician cannot calculate a responsible dose for you either. The honest answer is that the dose is unknown.

The 10mg Vial Math: Reconstitution and Units

If you are handling a 10 mg vial in a laboratory setting, the arithmetic is straightforward. Concentration equals the total powder divided by the volume of water added, and the volume per dose equals the dose divided by the concentration.

Bacteriostatic water addedConcentrationVolume containing 1 mgUnits on a U-100 syringe
1 mL10 mg/mL0.10 mL10 units
2 mL5 mg/mL0.20 mL20 units
3 mL3.3 mg/mL0.30 mL30 units
5 mL2 mg/mL0.50 mL50 units

Adding 2 mL of bacteriostatic water to a 10 mg vial creates a 5 mg/mL solution, so 1 mg occupies 0.2 mL, or 20 units on a U-100 syringe. Doubling the water halves the concentration and doubles the volume you draw for the same amount.

Details like 5-amino-1mq reconstitution and dosage get discussed constantly, yet the chemistry never changes: water volume only changes concentration, never the total amount in the vial. A 5-amino-1mq dosage calculator performs the same division and can help you double-check hand math, but it cannot tell you what dose is safe.

Oral vs Injection: What Actually Differs

The oral-versus-injectable question is mostly about bioavailability. A quaternary ammonium compound like 5-amino-1MQ carries a permanent positive charge, which makes it poorly absorbed through the gut. That is the main reason community protocols describe much larger oral amounts than injectable ones.

Discussions of 5-amino-1mq oral vs injection dosage usually break down along these lines:

  • Absorption: subcutaneous or intramuscular routes bypass first-pass metabolism; oral absorption is likely low and variable.
  • Onset: injection delivers the compound to circulation faster.
  • Sterility: injections require clean technique and properly stored bacteriostatic water; oral use avoids needles but not contamination risk.
  • Evidence: neither route has human trial data, so neither is "safer" in any documented sense.

5-amino-1MQ sold online is not a regulated pharmaceutical. Purity varies between vendors, and third-party certificates of analysis can be fabricated. Injecting a mislabeled or contaminated powder carries risks that have nothing to do with the molecule itself.

Reported issues in user forums include injection site irritation, fatigue, and gastrointestinal discomfort, though no formal adverse event data exists. Anyone with a medical condition, who is pregnant, or who takes prescription medication should consult a licensed healthcare professional before considering any research compound.

Possession and personal use may also violate state or federal rules depending on how a product is labeled and marketed. Check your local laws before ordering anything described as a research chemical.

How 5-Amino-1MQ Compares to Other Research Injectables

People researching 5-amino-1MQ often compare it with other injectable compounds sold for laboratory use. The table below summarizes the general evidence picture rather than endorsing any protocol.

CompoundTypical research vialReconstitution requiredHuman evidence
5-Amino-1MQ10 mg powderYesNone published
SLU-PP-332Varies by vendorYesNone published
L-carnitine (injectable)Pre-mixed solutionNoExtensive clinical use
DSIP5 mg powderYesLimited, dated studies

Comparisons like slu-pp-332 vs 5-amino-1mq come down to mechanism, not dose: SLU-PP-332 acts on estrogen-related receptor pathways, while 5-amino-1MQ targets NNMT. Both lack human trial data.

Compounds with decades of clinical use, such as L-carnitine, have documented dosing and monitoring standards. 5-amino-1MQ does not, and that difference matters far more than any forum chart.

A 10 mg vial is a package size, not a dose. Without human pharmacokinetic data, no reliable 5-amino-1MQ injection dosage exists, and anyone presenting a precise number is working from inference rather than evidence.

Frequently Asked Questions

How much 5-amino-1MQ should I inject from a 10mg vial?

There is no established human dose for 5-amino-1MQ. The 10 mg figure describes the total powder inside the vial, not how much you take at one time. Every amount you see posted online is anecdotal, and using a research chemical with no human safety data carries unknown risk.

How much bacteriostatic water do you add to a 10mg 5-amino-1MQ vial?

Common laboratory practice is to add 1 to 3 mL, which produces a concentration between 10 mg/mL and about 3.3 mg/mL. Adding 2 mL gives a simple 5 mg/mL solution, where 1 mg equals 0.2 mL, or 20 units on a U-100 insulin syringe. More water only dilutes the solution; it does not change the total 10 mg of powder in the vial.

Is 5-amino-1MQ legal or FDA-approved?

5-amino-1MQ is not FDA-approved for human use in the United States and is not a dietary supplement. It is sold as a research chemical labeled "for research use only." State laws on personal possession vary, and importing it for human consumption may violate federal rules.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.